Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mario Rivera-Izquierdo, Maria del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández-Martínez & José Luis Barranco-Quintana. (2020) Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review. Expert Review of Vaccines 19:8, pages 727-744.
Read now
Read now
Hong Zhao, Xiaoying Zhou & Yi-Hua Zhou. (2020) Hepatitis B vaccine development and implementation. Human Vaccines & Immunotherapeutics 16:7, pages 1533-1544.
Read now
Read now
Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros & Falko Panzer. (2019) Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. Human Vaccines & Immunotherapeutics 15:1, pages 235-241.
Read now
Read now
Articles from other publishers (28)
Marli Azevedo & Anil K. Patri. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
304
321
.
Jonaid Ahmad Malik, Gurpreet Kaur & Javed N. Agrewala. (2023) Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity. International Journal of Biological Macromolecules 253, pages 127252.
Crossref
Crossref
Ting-Ya Kuo, Jerry Che-Jui Chang, Yin-Chu Chien & Chyi-Feng Jan. (2023) The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study. Journal of the Formosan Medical Association.
Crossref
Crossref
Li Nie, Wei Hua, Xiuying Liu, Xinghuo Pang, Caiping Guo, Wei Zhang, Yakun Tian & Qian Qiu. (2023) Associated Factors and Immune Response to the Hepatitis B Vaccine with a Standard Schedule: A Prospective Study of People with HIV in China. Vaccines 11:5, pages 921.
Crossref
Crossref
Dan Guo, Jiazhen Dai, Rong Ju, Qifan Zhou, Nenghuan Wang, Chunhua Wu, Hui Tao, Hui Jing, Chen Zhu, Jinxian Mao & Jiayan Xu. (2023) The relationship between triglyceride, cholesterol and lipoprotein levels, and immune responses to hepatitis B vaccine. Frontiers in Medicine 10.
Crossref
Crossref
Ling Xu, Li Zhang, Shuang Kang, Xiaodi Li, Lianfeng Lu, Xiaosheng Liu, Xiaojing Song, Yanling Li, Xiaoxia Li, Wei Lyu, Wei Cao, Zhengyin Liu & Taisheng Li. (2023) Immune Responses to HBV Vaccine in People Living with HIV (PLWHs) Who Achieved Successful Treatment: A Prospective Cohort Study. Vaccines 11:2, pages 400.
Crossref
Crossref
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, Abyson Joseph, Ruchir Rastogi, Nupur Mehrotra Arora & Prabuddha K. Kundu. (2023) Platforms, advances, and technical challenges in virus-like particles-based vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Juan Wang, Chang-Hai Liu, Yuanji Ma, Xia Zhu, Liru Luo, Yulin Ji & Hong Tang. (2022) Two-year immune effect differences between the 0–1–2-month and 0–1–6-month HBV vaccination schedule in adults. BMC Infectious Diseases 22:1.
Crossref
Crossref
Tasneem Farhad, Keila Neves, Patrick Arbuthnot & Mohube Betty Maepa. (2022) Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics. Genes 13:11, pages 1941.
Crossref
Crossref
Dawid Pieper, Irma Hellbrecht, Linlu Zhao, Clemens Baur, Georgia Pick, Sarah Schneider, Thomas Harder, Kelsey Young, Andrea C. Tricco, Ella Westhaver & Matthew Tunis. (2022) Impact of industry sponsorship on the quality of systematic reviews of vaccines: a cross-sectional analysis of studies published from 2016 to 2019. Systematic Reviews 11:1.
Crossref
Crossref
Ira M. Jacobson, Robert S. Brown, Brian J. McMahon, Robert P. Perrillo & Robert Gish. (2022) An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus. Journal of Clinical Gastroenterology 56:6, pages 478-492.
Crossref
Crossref
Claudius U. Meyer & Fred Zepp. 2022. Vaccine Design. Vaccine Design
27
56
.
Fahima Chowdhury, Afroza Akter, Taufiqur Rahman Bhuiyan, Imam Tauheed, Tasnuva Ahmed, Faisal Ahmmed, Faez Ahmed, Mahbubul Karim, Mohammad Mainul Ahasan, Masudur Rahman Mia, Mir Mohammad Ibna Masud, Abdul Wahab Khan, Muhammad Masum Billah, Zebun Nahar, Imran Khan, Md. Rahad Hossain, A.Z.M. Ariful Islam, Alex S. Panday, Md. Muktadir Rahman Ashik & Firdausi Qadri. (2021) A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh. Vaccine 39:43, pages 6385-6390.
Crossref
Crossref
E. Seremba, P. Ocama, R. Ssekitoleko, H. Mayanja-Kizza, S.V. Adams, J. Orem, E. Katabira, S.J. Reynolds, R. Nabatanzi, C. Casper & W. Phipps. (2021) Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. Vaccine 39:8, pages 1265-1271.
Crossref
Crossref
Jacob Atsmon, Nathalie Machluf, Vered Yayon-gur, Cyril Sabbah, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic & Francisco Diaz-Mitoma. (2021) Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study. Vaccine 39:8, pages 1328-1332.
Crossref
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Crossref
Servet ÖZTÜRK, Merve KAÇAR, Semra TOPRAK, Onur ÇOLAK, Derya ÖZTÜRK & Canan AGALAR. (2020) Hepatit B Aşılama Verileri; İmmünsüpresif Hastalarda Tek Doz mu? Çift Doz mu?. Namık Kemal Tıp Dergisi.
Crossref
Crossref
Huiming Ye, Jing Teng, Zhiyuan Lin, Ye Wang & Xiaochun Fu. (2020) Analysis of HBsAg mutations in the 25 years after the implementation of the hepatitis B vaccination plan in China. Virus Genes 56:5, pages 546-556.
Crossref
Crossref
Peter L. Stern. (2020) Key steps in vaccine development. Annals of Allergy, Asthma & Immunology 125:1, pages 17-27.
Crossref
Crossref
Pierre Van Damme, Marc Dionne, Geert Leroux‐Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran & Nicolas Folschweiller. (2019)
Persistence of
HB
sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
. Journal of Viral Hepatitis 26:9, pages 1066-1075.
Crossref
Crossref
Paul F McKay, Deniz Cizmeci, Yoann Aldon, Jeroen Maertzdorf, January Weiner, Stefan HE Kaufmann, David JM Lewis, Robert A van den Berg, Giuseppe Del Giudice & Robin J Shattock. (2019) Identification of potential biomarkers of vaccine inflammation in mice. eLife 8.
Crossref
Crossref
Karin Neukam, Alicia Gutiérrez-Valencia, Silvia Llaves-Flores, Nuria Espinosa, Pompeyo Viciana & Luis F. López-Cortés. (2019) Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions. Vaccine 37:20, pages 2758-2763.
Crossref
Crossref
Krupa Naran, Trishana Nundalall, Shivan Chetty & Stefan Barth. (2018) Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases. Frontiers in Microbiology 9.
Crossref
Crossref
L. M. Khantimirova, T. Yu. Kozlova, E. L. Postnova, V. A. Shevtsov & A. V. Rukavishnikov. (2018) Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination. BIOpreparations. Prevention, Diagnosis, Treatment 18:4, pages 225-235.
Crossref
Crossref
Qingyao Daniel Huang & Seng-Gee Lim. (2018) New Advances in Hepatitis B Vaccination for Adults. Current Hepatology Reports 17:4, pages 466-474.
Crossref
Crossref
Ning Wang & Ting Wang. 2018. Immunization - Vaccine Adjuvant Delivery System and Strategies. Immunization - Vaccine Adjuvant Delivery System and Strategies.
Xuefen Li, Yumiao Xu, Yuejiao Dong, Xianzhi Yang, Bo Ye, Yiyin Wang & Yu Chen. (2018) Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses. Vaccine 36:18, pages 2442-2449.
Crossref
Crossref
Lie Nie, Wei Hua, Xiuying Liu, Xinghuo Pang, Caiping Guo, Wei Zhang, Yakun Tian & Qian Qiu. (2022) Associated Factors and Immune Response to Hepatitis B Vaccine With Standard Schedule: A Prospective Study of HIV -Infected Adults in China. SSRN Electronic Journal.
Crossref
Crossref